Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5407)
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
1,276
Price
$79.97
Total Value
$102.04K
Shares Held After
0
% of Holdings
100.0%
PALVELLA THERAPEUTICS, INC. (PVLA)
Goin Kathleen — Chief Operating Officer
Shares
3,026
Price
$79.16
Total Value
$239.53K
Shares Held After
1,276
% of Holdings
70.3%
Voyager Therapeutics, Inc. (VYGR)
Carter Todd Alfred — Chief Scientific Officer
Shares
3,301
Price
$3.44
Total Value
$11.36K
Shares Held After
149,892
% of Holdings
2.2%
ACCURAY INC (ARAY)
MAYER STEVEN F — Director
Shares
126,125
Price
$0.53
Total Value
$67.20K
Shares Held After
1,421,745
% of Holdings
8.9%
Cencora, Inc. (COR)
Mauch Robert P. — Director
Shares
1,333
Price
$359.46
Total Value
$479.16K
Shares Held After
65,393
% of Holdings
2.0%
Keros Therapeutics, Inc. (KROS)
Cho Esther — SVP, General Counsel
Shares
4,745
Price
$16.35
Total Value
$77.58K
Shares Held After
39,755
% of Holdings
10.7%
Voyager Therapeutics, Inc. (VYGR)
Sandrock Alfred — Director
Shares
11,732
Price
$3.41
Total Value
$40.01K
Shares Held After
498,257
% of Holdings
2.3%
Aveanna Healthcare Holdings, Inc. (AVAH)
Shaner Jeff — Chief Executive Officer
Shares
168,800
Price
$7.38
Total Value
$1.25M
Shares Held After
2,824,117
% of Holdings
5.6%
Aveanna Healthcare Holdings, Inc. (AVAH)
Buckhalter Matthew — Chief Financial Officer
Shares
13,167
Price
$7.38
Total Value
$97.21K
Shares Held After
542,755
% of Holdings
2.4%
Aveanna Healthcare Holdings, Inc. (AVAH)
Cunningham Patrick A. — Chief Compliance Officer
Shares
17,965
Price
$7.38
Total Value
$132.63K
Shares Held After
356,191
% of Holdings
4.8%
Aveanna Healthcare Holdings, Inc. (AVAH)
Stewart Deborah — SVP, Chief Accounting Officer
Shares
10,896
Price
$7.38
Total Value
$80.44K
Shares Held After
312,988
% of Holdings
3.4%
Aveanna Healthcare Holdings, Inc. (AVAH)
Reisz Edwin C. — Chief Administrative Officer
Shares
59,217
Price
$7.38
Total Value
$437.19K
Shares Held After
1,507,826
% of Holdings
3.8%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Farmer Michele — See Remarks
Shares
14,952
Price
$1.63
Total Value
$24.36K
Shares Held After
219,092
% of Holdings
6.4%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
Van Oene Mark — See Remarks
Shares
55,107
Price
$1.63
Total Value
$89.77K
Shares Held After
1,742,638
% of Holdings
3.1%
HEALTHCARE SERVICES GROUP INC (HCSG)
Orr Patrick J — EVP & Chief Revenue Officer
Shares
45,500
Price
$20.54
Total Value
$934.57K
Shares Held After
44,615
% of Holdings
50.5%
HEALTHCARE SERVICES GROUP INC (HCSG)
SHEA JOHN CHRISTOPHER — EVP & Chief Admin. Officer
Shares
38,857
Price
$20.36
Total Value
$791.13K
Shares Held After
29,292
% of Holdings
57.0%
PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB)
HENRY CHRISTIAN O — See Remarks
Shares
140,874
Price
$1.63
Total Value
$229.48K
Shares Held After
2,673,500
% of Holdings
5.0%
HEALTHCARE SERVICES GROUP INC (HCSG)
SHEA JOHN CHRISTOPHER — EVP & Chief Admin. Officer
Shares
15,500
Price
$20.52
Total Value
$318.06K
Shares Held After
29,292
% of Holdings
34.6%
RECURSION PHARMACEUTICALS, INC. (RXRX)
Taylor Ben R — Chief Financial Officer
Shares
13,426
Price
$3.08
Total Value
$41.35K
Shares Held After
1,195,349
% of Holdings
1.1%
KalVista Pharmaceuticals, Inc. (KALV)
Yea Christopher — CHIEF DEVELOPMENT OFFICER
Shares
1,109
Price
$15.00
Total Value
$16.64K
Shares Held After
224,173
% of Holdings
0.5%
KalVista Pharmaceuticals, Inc. (KALV)
Audhya Paul K. — CHIEF MEDICAL OFFICER
Shares
1,163
Price
$15.00
Total Value
$17.45K
Shares Held After
133,087
% of Holdings
0.9%
KalVista Pharmaceuticals, Inc. (KALV)
Palleiko Benjamin L — Director
Shares
1,038
Price
$15.00
Total Value
$15.57K
Shares Held After
429,667
% of Holdings
0.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,100
Price
$29.80
Total Value
$62.57K
Shares Held After
20,729
% of Holdings
9.2%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,983
Price
$29.04
Total Value
$86.64K
Shares Held After
22,829
% of Holdings
11.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
2,281
Price
$29.80
Total Value
$67.97K
Shares Held After
556,247
% of Holdings
0.4%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
3,552
Price
$29.05
Total Value
$103.19K
Shares Held After
558,528
% of Holdings
0.6%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
20,030
Price
$44.30
Total Value
$887.33K
Shares Held After
20,590
% of Holdings
49.3%
EXELIXIS, INC. (EXEL)
Smith Julie — Director
Shares
44,087
Price
$44.50
Total Value
$1.96M
Shares Held After
20,590
% of Holdings
68.2%
GERON CORP (GERN)
ROBERTSON MICHELLE — EVP, CHIEF FINANCIAL OFFICER
Shares
9,855
Price
$1.94
Total Value
$19.12K
Shares Held After
17,645
% of Holdings
35.8%
PTC THERAPEUTICS, INC. (PTCT)
Boulding Mark Elliott — EXEC. VP AND CLO
Shares
3,081
Price
$69.36
Total Value
$213.70K
Shares Held After
108,231
% of Holdings
2.8%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
3,684
Price
$65.89
Total Value
$242.73K
Shares Held After
71,343
% of Holdings
4.9%
Gemini Therapeutics, Inc. (GMTX)
Franchi Jean M. — Chief Financial Officer
Shares
3,397
Price
$65.01
Total Value
$220.84K
Shares Held After
75,027
% of Holdings
4.3%
Immunocore Holdings plc (IMCR)
Berman David M — HEAD OF R&D
Shares
5,965
Price
$32.35
Total Value
$192.97K
Shares Held After
5,859
% of Holdings
50.4%
Immunocore Holdings plc (IMCR)
St Leger Tina Amber — CHIEF HR OFFICER
Shares
1,000
Price
$32.35
Total Value
$32.35K
Shares Held After
1,119
% of Holdings
47.2%
Immunocore Holdings plc (IMCR)
GOLL JOHN — SVP, FINANCE & CAO
Shares
698
Price
$32.35
Total Value
$22.58K
Shares Held After
653
% of Holdings
51.7%
Immunocore Holdings plc (IMCR)
Jallal Bahija — Director
Shares
11,474
Price
$32.35
Total Value
$371.18K
Shares Held After
12,343
% of Holdings
48.2%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Tatsis Ourania — EVP, Chief Reg. & Quality Off.
Shares
368
Price
$473.68
Total Value
$174.31K
Shares Held After
48,650
% of Holdings
0.8%
Precision BioSciences, Inc. (DTIL)
SMITH J. JEFFERSON — Chief Research Officer
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
121,926
% of Holdings
3.9%
Precision BioSciences, Inc. (DTIL)
Amoroso Michael — Director
Shares
20,559
Price
$3.84
Total Value
$78.95K
Shares Held After
243,392
% of Holdings
7.8%
Precision BioSciences, Inc. (DTIL)
Scimeca Dario — General Counsel and Secretary
Shares
4,925
Price
$3.84
Total Value
$18.91K
Shares Held After
56,457
% of Holdings
8.0%
Precision BioSciences, Inc. (DTIL)
Kelly John Alexander — Chief Financial Officer
Shares
8,149
Price
$3.84
Total Value
$31.29K
Shares Held After
125,883
% of Holdings
6.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Ambrose Kristen — SVP & Chief Accounting Officer
Shares
638
Price
$473.68
Total Value
$302.21K
Shares Held After
7,750
% of Holdings
7.6%
Seer, Inc. (SEER)
Farokhzad Omid — Director
Shares
24,385
Price
$1.99
Total Value
$48.65K
Shares Held After
3,349,064
% of Holdings
0.7%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Atkinson Edward Morrow III — EVP, Chief Technical Ops. Off.
Shares
817
Price
$473.68
Total Value
$387.00K
Shares Held After
20,727
% of Holdings
3.8%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Biller Jonathan — EVP and Chief Legal Officer
Shares
1,244
Price
$473.68
Total Value
$589.26K
Shares Held After
15,748
% of Holdings
7.3%
Seer, Inc. (SEER)
Horn David R. — PRESIDENT & CFO
Shares
7,743
Price
$1.99
Total Value
$15.45K
Shares Held After
501,262
% of Holdings
1.5%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bunnage Mark E. — EVP, Chief Scientific Officer
Shares
1,182
Price
$473.68
Total Value
$559.89K
Shares Held After
8,486
% of Holdings
12.2%
Ceribell, Inc. (CBLL)
Parvizi Josef — Director
Shares
6,986
Price
$20.00
Total Value
$139.72K
Shares Held After
739,366
% of Holdings
0.9%
APTARGROUP, INC. (ATR)
Touya Gael — Segment President
Shares
3,500
Price
$141.35
Total Value
$494.74K
Shares Held After
27,963
% of Holdings
11.1%
Sintx Technologies, Inc. (SINT)
Anderson Mark Lewis — Director
Shares
3,000
Price
$3.02
Total Value
$9.06K
Shares Held After
18,000
% of Holdings
16.7%
Showing 2401–2450 of 5407 transactions (page 49 of 109)